| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Isavuconazole |
| Brand | Cresemba® |
| Indication | For the treatment of mucormycosis in adult patients for whom amphotericin B is inappropriate. |
| Assessment Process | |
| Rapid review commissioned | 11/04/2016 |
| Rapid review completed | 11/05/2016 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |
The HSE has approved reimbursement following confidential price negotiations: April 2018.